87 related articles for article (PubMed ID: 15237390)
1. Synthesis and evaluation of a dimer of 2-(4-pyridylmethyl)-1-indanone as a novel nonsteroidal aromatase inhibitor.
Gupta R; Jindal DP; Jit B; Narang G; Palusczak A; Hartmann RW
Arch Pharm (Weinheim); 2004 Jul; 337(7):398-401. PubMed ID: 15237390
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins.
Hartmann RW; Bayer H; Grün G
J Med Chem; 1994 Apr; 37(9):1275-81. PubMed ID: 8176705
[TBL] [Abstract][Full Text] [Related]
4. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
Kim YW; Hackett JC; Brueggemeier RW
J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241
[TBL] [Abstract][Full Text] [Related]
6. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.
Graves PE; Salhanick HA
Endocrinology; 1979 Jul; 105(1):52-7. PubMed ID: 446416
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biochemical evaluation of novel inhibitors of aromatase (AR) using an enhanced representation of the active site of AR derived from the consideration of the reaction mechanism.
Ahmed S; Amanuel Y
Biochem Biophys Res Commun; 2000 Jan; 267(1):356-61. PubMed ID: 10623624
[TBL] [Abstract][Full Text] [Related]
10. Aromatase is the major enzyme metabolizing buprenorphine in human placenta.
Deshmukh SV; Nanovskaya TN; Ahmed MS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1099-105. PubMed ID: 12808001
[TBL] [Abstract][Full Text] [Related]
11. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study.
van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740
[TBL] [Abstract][Full Text] [Related]
13. Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.
Gobbi S; Zimmer C; Belluti F; Rampa A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2010 Jul; 53(14):5347-51. PubMed ID: 20568782
[TBL] [Abstract][Full Text] [Related]
14. Studies of human placental aromatase.
Siiteri PK; Thompson EA
J Steroid Biochem; 1975; 6(3-4):317-22. PubMed ID: 810626
[No Abstract] [Full Text] [Related]
15. The effect of opiates on the activity of human placental aromatase/CYP19.
Zharikova OL; Deshmukh SV; Kumar M; Vargas R; Nanovskaya TN; Hankins GD; Ahmed MS
Biochem Pharmacol; 2007 Jan; 73(2):279-86. PubMed ID: 17118343
[TBL] [Abstract][Full Text] [Related]
16. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
ChemMedChem; 2007 Dec; 2(12):1750-62. PubMed ID: 17910019
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.
Pontillo J; Wu D; Ching B; Hudson S; Genicot MJ; Gao Y; Ewing T; Fleck BA; Gogas K; Aparicio A; Wang H; Wen J; Wade WS
Bioorg Med Chem Lett; 2008 Dec; 18(23):6151-5. PubMed ID: 18954981
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors.
Nativelle-Serpentini C; Moslemi S; Yous S; Park CH; Lesieur D; Sourdaine P; Séralini GE
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):119-27. PubMed ID: 15449726
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.
Numazawa M; Tominaga T; Watari Y; Tada Y
Steroids; 2006 May; 71(5):371-9. PubMed ID: 16476457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
